University of Twente Student Theses
Using multi-criteria decision analysis to evaluate the potential of biosimilars to lower costs in oncology
Tuenter, Hilde (2015) Using multi-criteria decision analysis to evaluate the potential of biosimilars to lower costs in oncology.
|
PDF
1MB |
| Abstract: | Even though biosimilars have the potential to bend down the cost curve of oncology by at least 10 percent, their actual uptake appeared to be less evident than expected. Currently, both patients and healthcare providers are not confident about the efficacy, safety and interchangeability of biosimilars compared with their reference product. The limited knowledge regarding biosimilars in oncology may have an impact on the attitudes and perceptions of stakeholders in oncology. To evaluate the potential of biosimilars to lower costs in oncology, it is important to determine the preferences of stakeholders in oncology for biosimilars. A multi-criteria decision analysis is designed to determine which factors stakeholders consider to be important with regard to the uptake of biosimilars in the Dutch oncology setting, to prioritize the role of post-marketing studies. |
| Item Type: | Essay (Master) |
| Faculty: | BMS: Behavioural, Management and Social Sciences |
| Subject: | 44 medicine |
| Programme: | Health Sciences MSc (66851) |
| Link to this item: | https://purl.utwente.nl/essays/67953 |
| Export this item as: | BibTeX EndNote HTML Citation Reference Manager |
Show download statistics for this publication
Show download statistics for this publicationRepository Staff Only: item control page